Affiliation:
1. Department of Anesthesiology and Perioperative Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
2. Department of Anesthesiology and Critical Care Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
3. Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas
4. University of Houston, Tillman J. Fertitta Family College of Medicine, Houston, Texas
5. University of Houston, Houston, Texas
6. Anesthesiology and Surgical Oncology Research Group, Houston, Texas.
Abstract
BACKGROUND:
Racial and ethnic differences in health care may result in significant morbidity. The objective of this study was to determine whether there was an association between a patient’s race or ethnicity and the receipt of an antiemetic agent preoperatively, during surgery, and in the recovery room.
METHODS:
A single-institution retrospective study of adult patients (>18 years) who had undergone cancer-related operating room procedures under anesthesia between March 2016 and August 2021 was conducted. A multivariable logistic regression model was fitted to estimate the effects of covariates on antiemetic administration.
RESULTS:
Of the 60,595 patients included in the study, 3053 (5.0%) self-identified as Asian, 5376 (8.9%) as Black, 8431 (13.9%) as Hispanic or Latino, 42,533 (70.2%) as White, and 1202 (2.0%) as belonging to another racial or ethnic group. Multivariable analyses showed significant associations between a patient’s race or ethnicity and the receipt of antiemetics in the preoperative holding area, operating room, and recovery room (all P < .001). In the preoperative holding area, White patients (8962 of 42,533 [21.1%]; odds ratio [OR], 1.188; 95% confidence interval [CI], 1.100–1.283; P < .001) had higher odds of receiving an antiemetic than Black patients (1006 of 5376 [18.7%]). Intraoperatively, the odds were significantly greater for Hispanic or Latino (7323 of 8431 [86.9%]; OR, 1.175; 95% CI, 1.065–1.297; P = .001) and patients who identified as belonging to another race (1078 of 1202 [89.7%]; OR, 1.582; 95% CI, 1.290–1.941; P < .001) than for Black patients (4468 of 5376 [83.1%]). In the recovery room, Asian (499 of 3053 [16.3%]; OR, 1.328; 95% CI: 1.127–1.561; P < .001), Hispanic or Latino (1335 of 8431 [15.8%]; OR, 1.208; 95% CI, 1.060–1.377; P < .005), and White patients (6533 of 42,533 [15.4%]; OR, 1.276; 95% CI, 1.140–1.427; P < .001) had significantly higher odds of receiving antiemetics than Black patients (646 of 5376 [12%]).
CONCLUSIONS:
This retrospective study suggests significant differences between the administrations of antiemetics to patients of different races or ethnicities, with Black patients often being less likely to receive an antiemetic than patients belonging to all other races or ethnicities.
Publisher
Ovid Technologies (Wolters Kluwer Health)